Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Buy
907
+195
+27% +$66.8K 0.03% 143
2026
Q1
$248K Hold
712
0.02% 154
2025
Q4
$228K Buy
712
+158
+29% +$50.1K 0.02% 163
2025
Q3
$165K Buy
554
+100
+22% +$29K 0.01% 178
2025
Q2
$135K Hold
454
0.01% 165
2025
Q1
$141K Hold
454
0.02% 156
2024
Q4
$118K Sell
454
-3
-0.7% -$890 0.01% 159
2024
Q3
$147K Sell
457
-56
-11% -$18.3K 0.02% 159
2024
Q2
$160K Sell
513
-263
-34% -$77.3K 0.02% 161
2024
Q1
$221K Buy
776
+77
+11% +$22.5K 0.02% 178
2023
Q4
$188K Hold
699
0.02% 177
2023
Q3
$188K Buy
+699
New +$174K 0.02% 177
2020
Q2
Sell
-108
Closed -$22K 75
2020
Q1
$22K Hold
108
0.01% 132
2019
Q4
$26K Buy
108
+60
+125% +$13.2K 0.01% 142
2019
Q3
$9K Hold
48
﹤0.01% 169
2019
Q2
$9K Sell
48
-16
-25% -$2.87K ﹤0.01% 161
2019
Q1
$12K Buy
64
+16
+33% +$3.06K ﹤0.01% 151
2018
Q4
$9K Buy
+48
New +$9.36K ﹤0.01% 159

Other funds holding AMGN

Salomon & Ludwin's AMGN Position: Q2 2026 in Review

Salomon & Ludwin increased its Amgen (AMGN) stake by 27% in Q2 2026, buying an estimated $66.8K and bringing the position to 907 shares worth $328K. The position accounts for 0.03% of the portfolio, ranked #143.

Salomon & Ludwin first reported a position in AMGN in Q4 2018 and has held it in 18 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Salomon & Ludwin held 907 shares of Amgen worth $328K as of Q2 2026.
  • Salomon & Ludwin bought 195 Amgen shares in Q2 2026, an estimated $66.8K.
  • Amgen made up 0.03% of Salomon & Ludwin's portfolio in Q2 2026, its #143 holding.
  • Salomon & Ludwin first reported a position in Amgen in Q4 2018 and has held it in 18 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.